1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Kidney Disease: new trials by email Literature Review of Kidney Disease trials Research Report on Kidney Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventing Sickle Cell Kidney Disease Losartan - Anemia, Sickle Cell, Sickle Cell Disease | Phase 2 | Terminated | University of Alabama at Birmingham | 1 | 2015-04-01 | 2024-04-03 |
Anemia, Sickle Cell (1) · Hypertension (1) · Kidney Diseases (1) · Proteinuria (1)
Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemoglobinopathies (1) · Male Urogenital Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Urination Disorders (1)
Losartan (1)
University of Alabama at Birmingham (1)
United States (1)
Jeffrey D Lebensburger, DO, MSPH (1)
K23HL127100 (1)